Differential Cell Sensitivity Between OTA and LPS Upon Releasing TNF-α
Overview
Affiliations
The release of tumor necrosis factor α (TNF-α) by ochratoxin A (OTA) was studied in various macrophage and non-macrophage cell lines and compared with E. coli lipopolysaccharide (LPS) as a standard TNF-α release agent. Cells were exposed either to 0, 2.5 or 12.5 µmol/L OTA, or to 0.1 µg/mL LPS, for up to 24 h. OTA at 2.5 µmol/L and LPS at 0.1 µg/mL were not toxic to the tested cells as indicated by viability markers. TNF-α was detected in the incubated cell medium of rat Kupffer cells, peritoneal rat macrophages, and the mouse monocyte macrophage cell line J774A.1: TNF-α concentrations were 1,000 pg/mL, 1,560 pg/mL, and 650 pg/mL, respectively, for 2.5 µmol/L OTA exposure and 3,000 pg/mL, 2,600 pg/mL, and 2,115 pg/mL, respectively, for LPS exposure. Rat liver sinusoidal endothelial cells, rat hepatocytes, human HepG2 cells, and mouse L929 cells lacked any cytokine response to OTA, but showed a significant release of TNF-α after LPS exposure, with the exception of HepG2 cells. In non-responsive cell lines, OTA lacked both any activation of NF-κB or the translocation of activated NF-κB to the cell nucleus, i.e., in mouse L929 cells. In J774A.1 cells, OTA mediated TNF-α release via the pRaf/MEK 1/2-NF-κB and p38-NF-κB pathways, whereas LPS used pRaf/MEK 1/2-NF-κB, but not p38-NF-κB pathways. In contrast, in L929 cells, LPS used other pathways to activate NF-κB. Our data indicate that only macrophages and macrophage derived cells respond to OTA and are considered as sources for TNF-α release upon OTA exposure.
Risk assessment of ochratoxin A in food.
Schrenk D, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B, Hogstrand C EFSA J. 2023; 18(5):e06113.
PMID: 37649524 PMC: 10464718. DOI: 10.2903/j.efsa.2020.6113.
Tiskratok W, Yamada M, Watanabe J, Pengyu Q, Kimura T, Egusa H Int J Mol Sci. 2023; 24(10).
PMID: 37240303 PMC: 10219368. DOI: 10.3390/ijms24108959.
Zhang Z, Liu J, Xiao M, Zhang Q, Liu Z, Liu M Nano Res. 2022; 16(4):5206-5215.
PMID: 36405984 PMC: 9643898. DOI: 10.1007/s12274-022-5102-z.
Zheng R, Qing H, Ma Q, Huo X, Huang S, Zhao L Toxins (Basel). 2022; 14(8).
PMID: 36006231 PMC: 9415193. DOI: 10.3390/toxins14080569.
Zhao J, Vykoukal J, Abdelsalam M, Recio-Boiles A, Huang Q, Qiao Y Nanotechnology. 2014; 25(40):405101.
PMID: 25211057 PMC: 4414337. DOI: 10.1088/0957-4484/25/40/405101.